p16INK4a promoter methylation and 9p21 allelic loss in colorectal carcinomas:: relation with immunohistochemical p16INK4a expression and with tumor budding

p16INK4a promoter methylation and 9p21 allelic loss in colorectal carcinomas:: relation with immunohistochemical p16INK4a expression and with tumor budding
复制标题

DOI:
10.1016/j.humpath.2006.01.005
复制
发表时间:
2006-05-01
期刊:
影响因子:
3.3
通讯作者:
Nizze, H
Nizze, H
中科院分区:
医学3区
文献类型:
--
作者:
Prall, F;Ostwald, C;Nizze, H

文献摘要

被引文献

相似文献

在结直肠癌中,已知p16(INK4a)失活通过等位基因丢失和启动子甲基化发生,但突变很少。p16(INK4a)在肿瘤芽中上调,并且随后的增殖停止可能是肿瘤芽生的先决条件。57结直肠癌从一个连续的系列进行了研究。使用组织匀浆的DNA,p16(INK4a)启动子甲基化被认为是在17 57肿瘤甲基化特异性聚合酶链反应,这可以证实使用DNA从激光捕获显微切割材料在这些情况下的16。17例肿瘤中6例出现启动子甲基化,免疫组化p16(INK4a)表达完全缺失。免疫组化p16(INK4a)表达的定量显示,与没有p16(INK4a)启动子甲基化的病例相比,其余病例的表达频率在统计学上较低。9例p21等位基因丢失,但p16(INK4a)表达未降低。p16(INK4a)在肿瘤芽中的表达对肿瘤出芽程度的线性回归,如在泛细胞角蛋白免疫染色上计数的,没有显示出相关性。p16(INK4a)基因启动子甲基化可完全抑制p16(INK4a)在结直肠癌中的表达。然而,在许多情况下,它对p16(INK4a)表达有明显的但仅是调节性的影响。可能的是,甲基化是杂合的,和/或结直肠癌中的嵌合体,和/或甲基化不是完全稳定的,但可以在癌细胞复制周期之间丢失。p16(INK4a)的上调似乎不是肿瘤出芽的严格要求,因此,缺乏相关性。(c)2006年爱思唯尔公司All rights reserved.
In colorectal carcinomas, p16(INK4a) inactivation is known to occur by allelic loss and by promoter methylation, but mutations are rare. p16(INK4a) is up-regulated in tumor buds, and the consequent shutdown of proliferation may be a prerequisite for tumor budding. Fifty-seven colorectal carcinomas from a consecutive series were investigated. Using DNA from tissue homogenates, p16(INK4a) promoter methylation was seen in 17 of 57 tumors by methylation-specific polymerase chain reaction, and this could be confirmed using DNA from laser-capture microdissected material in 16 of these cases. A total loss of immunohistochemical p16(INK4a) expression was seen in 6 of 17 tumors with promoter methylation. Quantification of immunohistochemical p16(INK4a) expression for the remaining I I cases revealed statistically lower frequencies of expression as compared with cases without p16(INK4a) promoter methylation. 9p21 allelic loss was observed in 9 cases, but p16(INK4a) expression in these carcinomas was not reduced. Attempted linear regression of p16(INK4a) expression in tumor buds on the degree of tumor budding, as counted on pan-cytokeratin immunostains, did not show a correlation. p16(INK4a) promoter methylation can completely abrogate p16(INK4a) expression in colorectal carcinomas. In many cases, however, it has an appreciable but only modulatory influence on p16(INK4a) expression. Possibly, methylations are heterozygous, and/or mosaic in colorectal carcinomas and/or methylations are not totally stable but can be lost between carcinoma cell replication cycles. Up-regulation of p16(INK4a) does not seem to be a strict requirement for tumor budding, hence, the absence of a correlation. (c) 2006 Elsevier Inc. All rights reserved.